Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
Arrowhead Pharmaceuticals
TCT 25: VICTORY Trial: Intravascular Lithotripsy vs Super-High-Pressure Balloons for Calcified Coronary Lesions
Author(s): Matthias Bossard Added: 4 months ago
TCT 2025 - The randomized VICTORY Study finds OCT-guided PCI involving lesion preparation with the OPN super-high-pressure non-compliant balloon is non-inferior to intravascular lithotropsy.Dr Matthias Bossard (Kantonsspital Lucerne, Lucerne, CH) joins us to discuss findings from the VICTORY Trial, a randomized, multicenter, non-inferiority comparison evaluating intravascular lithotripsy versus… View more

Intervention

MI/ACS
AF & EP in 2026: Five Things That Will Change Daily Practice
Author(s): Tom De Potter Added: 1 month ago
Dr Tom De Potter (Cardiovascular Center, OLV Hospital, Aalst, BE) joins us to share his expert perspective on the five key developments poised to transform atrial fibrillation and electrophysiology practice in 2026.This forward-looking discussion examines emerging technologies, evolving clinical evidence, and shifting treatment paradigms that will influence day-to-day decision-making in… View more

Electrophysiology & Arrhythmia
Li Li

Author

TCT 24: The ECLIPSE Trial
Author(s): Ajay J Kirtane Added: 1 year ago
TCT Conference 2024 - Routine use of orbital atherectomy system (OAS) did not improve minimal stent area (MSA) or target vessel failure (TVF) at one year compaared to conventional balloon angioplasty.Dr Ajay J Kirtane (Columbia University Medical Center and New York-Presbyterian Hospital, New York, US) joins us onsite at TCT Conference to discuss the findings from ECLIPSE (NCT03108456; Abbott… View more

Intervention